{"title":"COVID-19 Associated Imported <i>Plasmodium vivax</i> Malaria Relapse: First Reported Case and Literature Review.","authors":"Zubair Shahid, Nadia Karim, Fakhar Shahid, Zohaib Yousaf","doi":"10.2147/RRTM.S292157","DOIUrl":null,"url":null,"abstract":"<p><p><i>Plasmodium vivax</i> (<i>P. vivax</i>) is a protozoan parasite that causes vivax malaria. Disease relapse post-treatment is reported in <i>P. vivax</i> co-infection with other bacterial and parasitic infections, but <i>Plasmodium vivax</i> reactivation is not very common with viral infections. Early recognition and diagnosis of a <i>Plasmodium vivax</i> malaria relapse in a non-endemic region pose a diagnostic dilemma. COVID-19 co-infection compounds this dilemma due to overlapping symptoms. Early diagnosis and treatment are essential for a favorable clinical outcome. We report a middle-aged gentleman with high-grade fever and headaches who had COVID-19 and was found to have a relapse of <i>Plasmodium vivax</i> malaria.</p>","PeriodicalId":21138,"journal":{"name":"Research and Reports in Tropical Medicine","volume":null,"pages":null},"PeriodicalIF":3.1000,"publicationDate":"2021-05-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8121982/pdf/","citationCount":"12","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Research and Reports in Tropical Medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2147/RRTM.S292157","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2021/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}
引用次数: 12
Abstract
Plasmodium vivax (P. vivax) is a protozoan parasite that causes vivax malaria. Disease relapse post-treatment is reported in P. vivax co-infection with other bacterial and parasitic infections, but Plasmodium vivax reactivation is not very common with viral infections. Early recognition and diagnosis of a Plasmodium vivax malaria relapse in a non-endemic region pose a diagnostic dilemma. COVID-19 co-infection compounds this dilemma due to overlapping symptoms. Early diagnosis and treatment are essential for a favorable clinical outcome. We report a middle-aged gentleman with high-grade fever and headaches who had COVID-19 and was found to have a relapse of Plasmodium vivax malaria.